New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
07:21 EDTZMHZimmer sees FY13 adjusted EPS $5.65-$5.85, consensus $5.74
Sees FY13 revenue up 2.5%-4.5% on constant currency basis, consensus $4.63B. The Company estimates that foreign currency translation will decrease revenues by approximately 0.5% for the full year 2013, resulting in reported revenue growth between 2% and 4%. In 2013, the Company expects to continue global restructuring and transformation initiatives designed to streamline business operations and support functions. Savings from these initiatives will enable the Company to absorb the medical device excise tax, continue to support investments in innovation and commercialization of new products and technologies, expand global sales channels and drive sustained growth in earnings and cash flow. The programs to be completed in 2013 are expected to generate annualized pre-tax savings of more than $80 million, including $30 million to $40 million to be realized in 2013.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
14:48 EDTZMHZimmer, Stryker have mixed read through from J&J results, says Wells Fargo
Subscribe for More Information
April 13, 2015
17:07 EDTZMHZimmer announces extension of outside date for pending Biomet merger
Subscribe for More Information
April 9, 2015
09:25 EDTZMHBiomet results positive for Zimmer deal accretion, says Wells Fargo
Wells Fargo says the key takeaway from Bioment's Q3 results this morning was the company's "significant" margin improvement. The results give Wells more confidence that Zimmer's earnings accretion estimate for the acquisition is attainable and could mean potential upside.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use